In addition, a large group from Kaiser Permanente Health demonstrated a possible dose dependent increased risk of bladder cancer with prior pioglitazone use however this did not reach statistical significance [ 20 ].
← all excerpts
Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model.
1
—
—